Subretinal Gene Therapy

Christina Weng, MD, MBA, Timothy Murray, MD, MBA

Show Description +

Christina Weng, MD, MBA, gives insight on ongoing subretinal gene therapy pipeline candidates, specifically voretigene neparvovec for patients with a mutation of the RPE65 gene.

Posted: 3/24/2020

Keywords:

retina-meeting-recap

Up Next

Artificial Intelligence and Pediatric Retina

R.V. Paul Chan, MD

Diagnosis of Peripheral Elevations

Jay Duker, MD

Founders Lecture: Intraocular Sustained Drug Delivery

Glenn Jaffe, MD, Timothy Murray, MD, MBA

Neuroprotection for the Treatment of the Retina

Baruch Kuppermann, MD, PhD, Timothy Murray, MD, MBA

Best Approaches for Pediatric RD

Phil Ferrone, MD, Timothy Murray, MD, MBA

Perfluorocarbon Liquids: Pearls and Pitfalls

Carl Regillo, MD, Timothy Murray, MD, MBA

Curtin & Smith Lecture: Intraocular Tumors: A Look Into the Future

Carol Shields, MD, Timothy Murray, MD, MBA

SD-OCT and SS-OCT: What Is the Impact?

Giovanni Staurenghi, MD

Subretinal Gene Therapy

Christina Weng, MD, MBA, Timothy Murray, MD, MBA

Back to All Videos

Subretinal Gene Therapy

Christina Weng, MD, MBA, Timothy Murray, MD, MBA

Christina Weng, MD, MBA, gives insight on ongoing subretinal gene therapy pipeline candidates, specifically voretigene neparvovec for patients with a mutation of the RPE65 gene.

Posted: 3/24/2020

Keywords:

retina-meeting-recap

Please log in to leave a comment.

Meeting Coverage:

Aspen Retinal Detachment Society

Subretinal Gene Therapy

Up Next

Subretinal Gene Therapy

More From ARDS: 2020 Coverage